This is a working overview of quality control, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins, PARPs, and CD38-family enzymes consume NAD+ and produce nicotinamide and ADP-ribose-related products. These reactions link NAD+ availability to DNA repair, chromatin modification, and cellular signaling. Because the molecule is central to energy metabolism and regulation, changes in its concentration are studied in aging, immunity, and metabolic research. The balance between synthesis and consumption varies by tissue, developmental stage, and physiological state.
In humans, NAD+ can be synthesized from nicotinic acid, nicotinamide, nicotinamide riboside, and tryptophan through overlapping pathways. The salvage pathway recycles nicotinamide back to NAD+ and is often considered a major route in many tissues. Dietary precursors and intracellular recycling both contribute to the pool, but the quantitative importance of each source remains an active research question. NAD+ levels are not uniform across organs or cell compartments. Measurements in blood do not necessarily reflect concentrations inside tissues.
NAD+ is a dinucleotide composed of nicotinamide, ribose, and adenine linked by phosphate groups. Its full name is nicotinamide adenine dinucleotide, with "+" denoting the oxidized form. The molecule acts as a coenzyme in redox reactions, cycling between NAD+ and NADH. In cells, it participates in electron transfer during glycolysis, the citric acid cycle, and oxidative phosphorylation. It is distinct from NADP+, which carries an additional phosphate group and supports different biosynthetic reactions.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme built from two nucleotides joined by a phosphate linkage. One nucleotide carries adenine, and the other carries nicotinamide; the plus sign denotes a formal positive charge on the nicotinamide ring, not a free proton. In cells, NAD+ and its reduced partner NADH form a reversible redox pair. That pair participates in electron transfer reactions throughout metabolism. The abbreviation NAD+ is common in biochemistry, while NAD(H) sometimes denotes the combined pool.
The molecule was first described in the early twentieth century as a factor that promoted fermentation in yeast extracts. Later work linked it to hydrogen transfer and to the oxidation of nutrients in living tissues. Its structure was resolved as a dinucleotide, which explained why it could accept and donate electrons at specific enzyme sites. Today, NAD+ is recognized as a central substrate and signaling precursor, not merely a metabolic cofactor. Whether all observed NAD+ changes reflect causal signaling remains an open question.
| Property | Value | Notes |
|---|---|---|
| Common name | Nicotinamide adenine dinucleotide (oxidized) | Often shortened to NAD+ |
| Chemical class | Dinucleotide | Contains nicotinamide and adenine moieties |
| Molecular formula | C21H27N7O14P2 | Free acid form; charge depends on pH |
| Molar mass | About 663.43 g/mol | Calculated for C21H27N7O14P2 |
| CAS number | 53-84-9 | Common identifier for beta-NAD+ |
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a dinucleotide coenzyme built from an adenine nucleotide and a nicotinamide nucleotide joined by a pyrophosphate linkage. Its oxidized form carries a positive charge on the nicotinamide ring, while the reduced form, NADH, carries a hydride equivalent. The molecule participates in hundreds of oxidoreductase reactions, where it accepts or donates electrons and protons. Because it can cycle between oxidized and reduced states without net consumption, NAD+ functions as a reusable electron carrier rather than a fuel molecule.
In glycolysis, the tricarboxylic acid cycle, and fatty acid oxidation, NAD+ is reduced to NADH at specific dehydrogenase steps. NADH then delivers electrons to the mitochondrial electron transport chain, mainly at complex I, supporting oxidative phosphorylation and ATP production. The balance between NAD+ and NADH, often expressed as a ratio, influences metabolic flux and redox homeostasis in different cellular compartments. Cytosolic and mitochondrial pools are connected but not identical, and their ratios can differ substantially because of compartment-specific enzymes and transport systems.
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer its ADP-ribose moiety or remove acetyl groups. Sirtuins consume NAD+ during deacetylation, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 enzymes hydrolyze it to signaling metabolites. These consumption pathways mean that NAD+ availability can influence gene regulation, DNA repair, and calcium signaling. Cellular NAD+ concentrations decline in some tissues with age in animal models, but whether this decline is a cause or consequence of aging in humans remains an active open question.
Solid NAD+ is relatively stable when kept dry, cold, and protected from light. Aqueous solutions are more vulnerable to hydrolysis and can lose activity during repeated freeze-thaw cycles or prolonged storage at ambient temperature. Stability depends on pH, ionic strength, and the presence of degrading enzymes or metal ions. For many laboratory uses, aliquots are stored frozen and thawed only once. Exact degradation rates vary by matrix, so stability should be checked for each application rather than assumed.
Laboratory handling of NAD+ follows standard practices for hygroscopic fine chemicals. Personnel typically avoid inhalation and skin contact, use gloves and eye protection, and work in a ventilated area. Quality control may include ultraviolet absorbance at the nicotinamide maximum, chromatographic purity, water content, and identity confirmation by mass spectrometry. Because commercial preparations can contain counterions, residual solvents, or related nucleotides, a certificate of analysis helps verify the material. Researchers should confirm that the form supplied matches the intended assay.
Laboratory measurement of NAD+ often begins with rapid quenching of cell or tissue samples to prevent enzymatic conversion. Acidic or alkaline extraction can precipitate proteins, but the chosen method affects recovery of oxidized and reduced forms. Enzymatic cycling assays provide high sensitivity by amplifying a NAD+-dependent reaction. High-performance liquid chromatography and mass spectrometry offer separation and structural confirmation. Each method has trade-offs in throughput, specificity, and the ability to distinguish NAD+ from close analogues.
Purified NAD+ is typically supplied as a white to off-white powder and stored desiccated at low temperature. Airtight containers limit moisture uptake, while protection from light reduces degradation of the nicotinamide ring. Aqueous stock solutions are less stable than solid material and are often aliquoted before freezing. Repeated freeze-thaw cycles can lower integrity, so working portions are kept separate. Purity is commonly checked by ultraviolet absorbance near 260 nm, high-performance liquid chromatography, or mass spectrometry.
Stability studies show that NAD+ can hydrolyze under prolonged heat, extreme pH, or microbial contamination. Phosphate buffers near neutral pH are often used for short-term handling, though exact stability depends on concentration, temperature, and matrix. In biological samples, endogenous enzymes can rapidly degrade NAD+, making cold chain and fast processing important. Analytical reports should state extraction conditions, internal standards, and validation parameters. Without those details, comparisons across studies remain difficult and potentially misleading.
NAD+ is a dinucleotide composed of adenine, ribose, and nicotinamide moieties linked by phosphate groups. Its oxidized form carries a positive charge on the nicotinamide ring, which enables reversible hydride transfer. The molecule functions as a coenzyme in oxidoreductase reactions rather than as a dietary vitamin in its intact form. Cells maintain separate pools in cytoplasm, mitochondria, and nucleus. This compartmentalization allows distinct redox environments while preserving a shared chemical identity.
In glycolysis, NAD+ accepts electrons during the oxidation of glyceraldehyde-3-phosphate, forming NADH. The tricarboxylic acid cycle and fatty acid oxidation also generate NADH, which donates electrons to the mitochondrial electron transport chain. This flow supports ATP synthesis and helps maintain the redox balance of the cell. Other dehydrogenases use NAD+ as a cofactor for biosynthetic reductions and detoxification reactions. NADH is later reoxidized to sustain continued flux through these pathways.
Beyond electron transfer, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer ADP-ribose units. Sirtuins, poly(ADP-ribose) polymerases, and CD38 consume NAD+ in regulatory reactions. These activities link NAD+ availability to DNA repair, chromatin modification, calcium signaling, and metabolic stress responses. Because consumption can exceed biosynthesis under some conditions, cellular NAD+ levels are dynamic rather than fixed. Enzyme affinity and local synthesis also influence how much NAD+ is available for signaling.
On 5 March 2013, Olofsson submitted his 24-page application for a new trial to the Supreme Court, where he, among other things, withdrew his involvement. The application was rejected in April 2013. As early as 2010, Olofsson applied for relocation to Belgium in the hope of a shorter sentence. The move from Kumla Prison in Sweden was delayed for several years and did not take place until the end of 2016 - then against his will - after Swedish and Belgian representatives agreed that he would be imprisoned for at least as long in Vorst Prison in Belgium. In February 2017, Olofsson turned 70 years old and was granted new Swedish citizenship. In October 2017, he was rejected in a Belgian court on his application for an ankle monitor. Olofsson demanded relocation back to Sweden. Belgium granted the application but in November 2017 Sweden rejected it.
=== Sigma bond cleavage === The ionization of alkanes weakens the C-C bond, ultimately resulting in the decomposition. As the bond breaks, a charged, even electron species (R+) and a neutral radical species (R•) are generated. Highly substituted carbocations are more stable than the nonsubstituted ones. An example is depicted below.
In September 2008, Aboitiz Equity Ventures decided to quit the shipping business to focus on its core businesses, namely power and financial services, and announced the sale of its controlling 77% stake in Aboitiz Transport System to KGLI‑NM Holdings, a joint venture between Negros Navigation and Dutch investors, with plans to acquire the remaining shares and potentially delist the company, but due to financing difficulties during the global financial crisis, KGLI‑NM was unable to complete the full buyout, paid only a P100 million option fee, and eventually withdrew its offer in May 2009, terminating the agreement. On December 1, 2010, Aboitiz Equity Ventures sold its transport business to Negros Navigation Co. Inc. (NENACO) for US$105 million, transferring all logistics and shipping operations under new ownership. At the same time, the China–ASEAN Investment Cooperation Fund, a Netherlands-based private equity firm owned by the Government of the People's Republic of China, acquired a controlling stake in NENACO through an equity infusion. In 2012, the company was reorganized and rebranded as 2GO Group Inc. with its brands SuperFerry, SuperCat, and Cebu Ferries merged with Negros Navigation to form 2GO Travel. In 2016, SM Investments Corporation (SMIC) and Chelsea Logistics and Infrastructure Holdings Corp. (owned by Dennis Uy) jointly acquired a major stake in 2GO Group Inc. In 2021, Chelsea Logistics sold its shares to SMIC, making 2GO a full subsidiary of SM Investments Corporation.
Sources: en.wikipedia.org
Vaccinations of animals are used both to prevent their contracting diseases and to prevent transmission of disease to humans. Both animals kept as pets and animals raised as livestock are routinely vaccinated. In some instances, wild populations may be vaccinated. This is sometimes accomplished with vaccine-laced food spread in a disease-prone area and has been used to attempt to control rabies in raccoons. Where rabies occurs, rabies vaccination of dogs may be required by law. Other canine vaccines include canine distemper, canine parvovirus, infectious canine hepatitis, adenovirus-2, leptospirosis, Bordetella, canine parainfluenza virus, and Lyme disease, among others. Cases of veterinary vaccines used in humans have been documented, whether intentional or accidental, with some cases of resultant illness, most notably with brucellosis. However, the reporting of such cases is rare and very little has been studied about the safety and results of such practices. With the advent of aerosol vaccination in veterinary clinics, human exposure to pathogens not naturally carried in humans, such as Bordetella bronchiseptica, has likely increased in recent years. In some cases, most notably rabies, the parallel veterinary vaccine against a pathogen may be as much as orders of magnitude more economical than the human one.
=== New approaches to target biofilms === The application of nanoparticles (NP) are one of novel promising techniques to target biofilms due to their high surface-area-to-volume ratio, their ability to penetrate to the deeper layers of biofilms and the capacity to releasing antimicrobial agents in a controlled way. Studying NP-EPS interactions could provide deeper understanding on how to develop more effective nanoparticles. "smart release" nanocarriers that can penetrate biofilms and be triggered by pathogenic microenvironments to deliver drugs or multifunctional compounds, such as catalytic nanoparticles to aptamers, dendrimers, and bioactive peptides) have been developed to disrupt the EPS and the viability or metabolic activity of the embedded bacteria. Some factors that would alter the potentials of the NP to transport antimicrobial agents into the biofilm include physicochemical interactions of the NP with EPS components, the characteristics of the water spaces (pores) within the EPS matrix and the EPS matrix viscosity. Size and surface properties (charge and functional groups) of the NPs are the major determinants of the penetration in and the interaction with the EPS. Another potential antibiofilm strategy is phage therapy. Bacteriophages, viruses that invade specific bacterial host cells, were suggested to be effective agents in penetrating biofilms.
=== Sales === According to Newell, Half-Life was budgeted with the expectation of lifetime sales of around 180,000 copies. However, it was a surprise hit. In the United States, it debuted at #8 on PC Data's weekly PC game sales chart for the November 15–21 period, with an average retail price (ARP) of $49. It rose to sixth place the following week, before dropping to position 10 for the week ending December 5. During the December 6–12 period, the game climbed back to sixth place; by this time, its ARP had dropped to $36. It placed between sixth and eighth on PC Data's weekly charts through the end of December, and its ARP rose back to $45 by the week ending January 2. PC Data declared Half-Life November's sixth-best-selling PC game in the United States, a position it held for the month of December. While its U.S. sales were below 100,000 copies by November 30, it sold 212,173 copies and earned revenues of $8.6 million in the United States by the end of 1998. In January 1999, Half-Life debuted at #3 on Chart-Track's PC game sales rankings for the United Kingdom, and remained in PC Data's weekly top 10 for the entire month, peaking at #4. By January 19, after two full months of availability, global sales of Half-Life surpassed 500,000 units. In the United States, it was the fifth-best-selling PC game for the month of January. On PC Data's weekly charts, it rose to #2 from February 7–20, with an ARP of $35. Holding a position in the weekly top 10 for the rest of February, it climbed to fourth for the month.
Sources: en.wikipedia.org
The plus sign indicates the oxidized form of nicotinamide adenine dinucleotide, which can accept electrons. When it accepts electrons, it becomes NADH. The two forms together support redox reactions in cells.
No. NAD+ is the oxidized form and NADH is the reduced form. They differ by two electrons and a proton equivalent, and cells interconvert them during metabolism.
Yes. NAD+ is present in all living cells and is required for fundamental metabolic reactions. Its concentration varies by tissue, compartment, and time.
It indicates a formal positive charge on the nicotinamide ring. The molecule is not simply a protonated acid, and the charge is part of its redox chemistry.